Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04971772Active Not Recruiting

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

Role: collaborator

NCT04503395Not ApplicableRecruiting

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

Role: lead

NCT04299906Not ApplicableUnknown

SOLARIS Peripheral PMCF Trial

Role: collaborator

NCT05543096Completed

PMCF Study for Cardiology Access Procedures

Role: collaborator

NCT05444660Completed

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Role: collaborator

NCT05312580Completed

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Role: collaborator

NCT05267548Unknown

Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries

Role: collaborator

All 7 trials loaded